600750 华润江中
已收盘 03-26 15:00:00
资讯
新帖
简况
研报掘金丨开源证券:维持华润江中“买入”评级,“内生+外延”蓄力发展
中金财经 · 03-26 16:28
研报掘金丨开源证券:维持华润江中“买入”评级,“内生+外延”蓄力发展
【机构调研记录】创金合信基金调研中粮科工、华润江中等5只个股(附名单)
证券之星 · 03-25 08:15
【机构调研记录】创金合信基金调研中粮科工、华润江中等5只个股(附名单)
股市必读:华润江中(600750)3月24日披露最新机构调研信息
证券之星 · 03-25 01:30
股市必读:华润江中(600750)3月24日披露最新机构调研信息
3月23日华润江中跌5.12%,华泰柏瑞中证红利低波动ETF基金重仓该股
证券之星 · 03-23
3月23日华润江中跌5.12%,华泰柏瑞中证红利低波动ETF基金重仓该股
华润江中(600750)披露2025年年度报告,3月20日股价上涨6.14%
证券之星 · 03-20
华润江中(600750)披露2025年年度报告,3月20日股价上涨6.14%
华润江中(600750.SH)发布2025年度业绩,归母净利润9.07亿元,同比增长15.03%
智通财经 · 03-19
华润江中(600750.SH)发布2025年度业绩,归母净利润9.07亿元,同比增长15.03%
华润江中最新公告:拟使用不超25亿元闲置自有资金进行委托理财
证券之星 · 03-19
华润江中最新公告:拟使用不超25亿元闲置自有资金进行委托理财
华润江中(600750)披露第二期限制性股票激励计划预留授予结果,2月24日股价下跌0.44%
证券之星 · 02-24
华润江中(600750)披露第二期限制性股票激励计划预留授予结果,2月24日股价下跌0.44%
华润江中公布国际专利申请:“健胃消食片在制备治疗肠易激综合征药物中的应用”
证券之星 · 02-21
华润江中公布国际专利申请:“健胃消食片在制备治疗肠易激综合征药物中的应用”
每周股票复盘:华润江中(600750)完成限制性股票预留授予
证券之星 · 02-15
每周股票复盘:华润江中(600750)完成限制性股票预留授予
每周股票复盘:华润江中(600750)向28人授66万股限制性股票
证券之星 · 02-08
每周股票复盘:华润江中(600750)向28人授66万股限制性股票
华润江中(600750)披露第二期限制性股票激励计划预留授予公告,2月3日股价上涨2.19%
证券之星 · 02-03
华润江中(600750)披露第二期限制性股票激励计划预留授予公告,2月3日股价上涨2.19%
每周股票复盘:华润江中(600750)证券简称2026年1月30日启用
证券之星 · 02-01
每周股票复盘:华润江中(600750)证券简称2026年1月30日启用
江中药业最新公告:证券简称变更为华润江中
证券之星 · 01-26
江中药业最新公告:证券简称变更为华润江中
每周股票复盘:江中药业(600750)净利增14.96%
证券之星 · 01-25
每周股票复盘:江中药业(600750)净利增14.96%
江中药业(600750)披露2025年年度业绩快报,1月23日股价上涨3.08%
证券之星 · 01-23
江中药业(600750)披露2025年年度业绩快报,1月23日股价上涨3.08%
华润医药(03320):江中药业2025年实现归母净利9.06亿元 同比增长14.96%
智通财经 · 01-23
华润医药(03320):江中药业2025年实现归母净利9.06亿元 同比增长14.96%
阿里健康上线首个自研医学大模型;江中药业证券简称变为华润江中
21世纪经济报道 · 01-20
阿里健康上线首个自研医学大模型;江中药业证券简称变为华润江中
江中药业(600750)披露拟变更证券简称公告,1月19日股价上涨0.44%
证券之星 · 01-19
江中药业(600750)披露拟变更证券简称公告,1月19日股价上涨0.44%
江中药业拟更名华润江中药业股份有限公司
美股速递 · 01-19
江中药业拟更名华润江中药业股份有限公司
加载更多
公司概况
公司名称:
华润江中药业股份有限公司
所属行业:
医药制造业
上市日期:
1996-09-23
主营业务:
华润江中药业股份有限公司的主营业务是药品和大健康产品的生产、研发与销售。公司的主要产品是健胃消食片、乳酸菌素片、双歧杆菌三联活菌肠溶胶囊、多维元素片、复方草珊瑚含片、复方鲜竹沥液、川贝枇杷胶囊、牛黄蛇胆川贝液、复方瓜子金颗粒、氨咖黄敏口服溶液等。公司累计授权专利300余项,参与2项国家标准、20余项中药饮片炮制规范的制定,荣获国家科学技术进步奖二等奖1项,省级科技进步奖4项,连续三年在国务院国资委“科改示范企业”专项考核中获评“优秀”。
发行价格:
6.80
{"stockData":{"symbol":"600750","market":"SH","secType":"STK","nameCN":"华润江中","latestPrice":25.83,"timestamp":1774508401000,"preClose":25.99,"halted":0,"volume":4992978,"delay":0,"changeRate":-0.0062,"floatShares":629000000,"shares":636000000,"eps":1.6129,"marketStatus":"已收盘","change":-0.16,"latestTime":"03-26 15:00:00","open":26,"high":26.13,"low":25.6,"amount":129000000,"amplitude":0.0204,"askPrice":25.83,"askSize":15,"bidPrice":25.82,"bidSize":4,"shortable":0,"etf":0,"ttmEps":1.6129,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1774575000000},"marketStatusCode":5,"adr":0,"adjPreClose":25.99,"symbolType":"stock","openAndCloseTimeList":[[1774488600000,1774495800000],[1774501200000,1774508400000]],"highLimit":28.59,"lowLimit":23.39,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":635613289,"isCdr":false,"pbRate":4.08,"roa":"--","peRate":16.014632,"roe":"22.75%","epsLYR":1.43,"committee":-0.677778,"marketValue":16418000000,"turnoverRate":0.0079,"status":1,"floatMarketCap":16239000000},"requestUrl":"/m/hq/s/600750","defaultTab":"news","newsList":[{"id":"2622837254","title":"研报掘金丨开源证券:维持华润江中“买入”评级,“内生+外延”蓄力发展","url":"https://stock-news.laohu8.com/highlight/detail?id=2622837254","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622837254?lang=zh_cn&edition=full","pubTime":"2026-03-26 16:28","pubTimestamp":1774513681,"startTime":"0","endTime":"0","summary":"开源证券研报指出,华润江中2025年业绩稳健提升,“内生+外延”蓄力发展。健康消费品营收增长领先,各产品板块毛利率均稳中有进。内生方面,公司非处方药业务将坚持以品牌驱动为核心,夯实“家中常备药”定位,巩固胃肠品类的市场领导地位,做大补益维矿、补强咽喉咳喘、拓展慢病特色等品类,以产品集群巩固品类发展。看好公司内生持续稳健发展潜力,维持2026-2027年并新增2028年盈利预测,维持“买入”评级。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260326/32101146.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["161027","600750"],"gpt_icon":0},{"id":"2622032014","title":"【机构调研记录】创金合信基金调研中粮科工、华润江中等5只个股(附名单)","url":"https://stock-news.laohu8.com/highlight/detail?id=2622032014","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622032014?lang=zh_cn&edition=full","pubTime":"2026-03-25 08:15","pubTimestamp":1774397729,"startTime":"0","endTime":"0","summary":"证券之星消息,根据市场公开信息及3月24日披露的机构调研信息,创金合信基金近期对5家上市公司进行了调研,相关名单如下:1)中粮科工 调研纪要:“十五五”期间,公司将推动一体化改革从 1.0 版本向 2.0 版本跃升,紧扣“3+3+1”业务体系变革要求,设立科创中心和科技管理部、数智化事业部、国际事业部,提升科技创新与国际布局能力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032500010461.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600750","BK0175","BK0028","BK0188","301058","BK0221","BK0239"],"gpt_icon":0},{"id":"2622309239","title":"股市必读:华润江中(600750)3月24日披露最新机构调研信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2622309239","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622309239?lang=zh_cn&edition=full","pubTime":"2026-03-25 01:30","pubTimestamp":1774373437,"startTime":"0","endTime":"0","summary":"截至2026年3月24日收盘,华润江中报收于25.61元,下跌0.58%,换手率1.29%,成交量8.11万手,成交额2.08亿元。当日关注点来自交易信息汇总:3月24日主力资金净流出990.71万元,占总成交额4.75%。2025年营收同比下降主因行业承压、终端需求变化及渠道调整,但盈利改善源于精细化管理带来的成本优化及高毛利产品占比提升。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032500003110.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0028","BK0188","600750","BK0175"],"gpt_icon":0},{"id":"2621161775","title":"3月23日华润江中跌5.12%,华泰柏瑞中证红利低波动ETF基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2621161775","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621161775?lang=zh_cn&edition=full","pubTime":"2026-03-23 16:21","pubTimestamp":1774254093,"startTime":"0","endTime":"0","summary":"证券之星消息,3月23日华润江中跌5.12%,收盘报25.76元,换手率2.33%,成交量14.65万手,成交额3.87亿元。根据2025基金年报公募基金重仓股数据,重仓该股的公募基金共30家,其中持有数量最多的公募基金为华泰柏瑞基金的华泰柏瑞中证红利低波动ETF。华泰柏瑞中证红利低波动ETF目前规模为267.54亿元,最新净值1.1971,较上一交易日下跌0.3%,近一年上涨8.41%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032300024654.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0188","BK0239","BK0175","000922.SH","600750"],"gpt_icon":0},{"id":"2620784165","title":"华润江中(600750)披露2025年年度报告,3月20日股价上涨6.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2620784165","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620784165?lang=zh_cn&edition=full","pubTime":"2026-03-20 17:39","pubTimestamp":1773999546,"startTime":"0","endTime":"0","summary":"截至2026年3月20日收盘,华润江中报收于27.15元,较前一交易日上涨6.14%,最新总市值为172.57亿元。该股当日开盘26.0元,最高27.75元,最低25.93元,成交额达3.83亿元,换手率为2.25%。华润江中药业股份有限公司于2026年3月20日披露《2025年年度报告》。若包含2025年半年度已分派的31,749.80万元,全年现金分红合计87,683.77万元,占年度净利润的96.71%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032000030911.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0175","600750","BK0028","BK0239","BK0188"],"gpt_icon":0},{"id":"2620463972","title":"华润江中(600750.SH)发布2025年度业绩,归母净利润9.07亿元,同比增长15.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2620463972","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620463972?lang=zh_cn&edition=full","pubTime":"2026-03-19 17:51","pubTimestamp":1773913900,"startTime":"0","endTime":"0","summary":"智通财经APP讯,华润江中(600750.SH)发布2025年年度报告,报告期内,公司实现营业收入42.2亿元,同比下降4.87%。实现归属于上市公司股东的净利润9.07亿元,同比增长15.03%。实现归属于上市公司股东的扣除非经常性损益的净利润8.33亿元,同比增长11.22%。基本每股收益为1.43元。拟每10股分配现金红利8.8元(含税)。报告期内,公司主营业务毛利率为65.50%,较上年同期增加1.53个百分点。其中医药工业毛利率65.48%,酒类毛利率为78.06%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1415995.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"华润江中(600750.SH)发布2025年度业绩,归母净利润9.07亿元,同比增长15.03%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["600750"],"gpt_icon":0},{"id":"2620245084","title":"华润江中最新公告:拟使用不超25亿元闲置自有资金进行委托理财","url":"https://stock-news.laohu8.com/highlight/detail?id=2620245084","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620245084?lang=zh_cn&edition=full","pubTime":"2026-03-19 17:39","pubTimestamp":1773913188,"startTime":"0","endTime":"0","summary":"华润江中(600750.SH)公告称,公司拟使用不超过25亿元的闲置自有资金进行委托理财,投资品种包括银行存款、大额可转让存单、风险评级R2及以下的理财产品、货币市场基金及信托产品,单笔期限不超过六个月。该事项已经公司第十届董事会第十三次会议审议通过,尚需提交2025年年度股东大会审议。资金来源为公司自有资金,不会影响主营业务正常开展。公司强调将严格控制风险,确保资金安全。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031900030786.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0188","BK0028","BK0175","600750"],"gpt_icon":0},{"id":"2613188267","title":"华润江中(600750)披露第二期限制性股票激励计划预留授予结果,2月24日股价下跌0.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2613188267","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613188267?lang=zh_cn&edition=full","pubTime":"2026-02-24 19:11","pubTimestamp":1771931482,"startTime":"0","endTime":"0","summary":"截至2026年2月24日收盘,华润江中报收于24.85元,较前一交易日下跌0.44%,最新总市值为157.95亿元。华润江中近日披露《关于第二期限制性股票激励计划预留授予结果的公告》。公告显示,公司完成第二期限制性股票激励计划预留授予登记工作,授予日为2026年2月3日,登记日为2026年2月12日,向28名激励对象授予66万股限制性股票,授予价格为13.70元/股,股票来源为定向发行A股普通股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022400038479.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600750","BK0239","BK0028","BK0175","BK0188"],"gpt_icon":0},{"id":"2613213001","title":"华润江中公布国际专利申请:“健胃消食片在制备治疗肠易激综合征药物中的应用”","url":"https://stock-news.laohu8.com/highlight/detail?id=2613213001","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613213001?lang=zh_cn&edition=full","pubTime":"2026-02-21 08:02","pubTimestamp":1771632160,"startTime":"0","endTime":"0","summary":"证券之星消息,根据企查查数据显示华润江中(600750)公布了一项国际专利申请,专利名为“健胃消食片在制备治疗肠易激综合征药物中的应用”,专利申请号为PCT/CN2025/092809,国际公布日为2026年2月19日。专利详情如下:图片来源:世界知识产权组织(WIPO)今年以来华润江中已公布的国际专利申请1个。结合公司2025年中报财务数据,2025上半年公司在研发方面投入了6742.93万元,同比减1.79%。数据来源:企查查以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022100000360.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","600750","BK0175","BK0188","BK0239"],"gpt_icon":0},{"id":"2611987145","title":"每周股票复盘:华润江中(600750)完成限制性股票预留授予","url":"https://stock-news.laohu8.com/highlight/detail?id=2611987145","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611987145?lang=zh_cn&edition=full","pubTime":"2026-02-15 02:11","pubTimestamp":1771092670,"startTime":"0","endTime":"0","summary":"截至2026年2月13日收盘,华润江中报收于24.96元,较上周的25.2元下跌0.95%。本周,华润江中2月11日盘中最高价报25.74元。华润江中当前最新总市值158.48亿元,在中药板块市值排名15/67,在两市A股市值排名1350/5189。本周关注点公司公告汇总:华润江中完成第二期限制性股票激励计划预留授予,向28名激励对象授予66万股,授予价格13.70元/股。限制性股票将在24个月、36个月、48个月后分三期解除限售,解除限售比例分别为33%、33%、34%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026021500000660.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0175","BK0239","BK0188","600750","BK0028"],"gpt_icon":0},{"id":"2609261885","title":"每周股票复盘:华润江中(600750)向28人授66万股限制性股票","url":"https://stock-news.laohu8.com/highlight/detail?id=2609261885","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609261885?lang=zh_cn&edition=full","pubTime":"2026-02-08 03:01","pubTimestamp":1770490874,"startTime":"0","endTime":"0","summary":"截至2026年2月6日收盘,华润江中报收于25.2元,较上周的24.86元上涨1.37%。本周,华润江中2月6日盘中最高价报25.89元,股价触及近一年最高点。华润江中当前最新总市值160.01亿元,在中药板块市值排名15/67,在两市A股市值排名1297/5186。本周关注点公司公告汇总:华润江中向28名激励对象授予66万股限制性股票,授予价格为13.70元/股。本次授予限制性股票总数为66.00万股,占公司目前总股本的0.10%,股票来源为公司向激励对象定向发行A股普通股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020800001057.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0188","BK0028","BK0175","600750"],"gpt_icon":0},{"id":"2608877822","title":"华润江中(600750)披露第二期限制性股票激励计划预留授予公告,2月3日股价上涨2.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2608877822","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608877822?lang=zh_cn&edition=full","pubTime":"2026-02-03 22:23","pubTimestamp":1770128600,"startTime":"0","endTime":"0","summary":"截至2026年2月3日收盘,华润江中报收于25.2元,较前一交易日上涨2.19%,最新总市值为160.01亿元。该股当日开盘24.97元,最高25.3元,最低24.66元,成交额达1.83亿元,换手率为1.16%。公告显示,公司于2026年2月3日召开董事会,审议通过向第二期限制性股票激励计划的28名激励对象授予预留限制性股票。本次授予将对公司财务状况产生一定影响,预计股份支付费用总额为759万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020300043179.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0175","600750","BK0028","BK0188","BK0239"],"gpt_icon":0},{"id":"2608077245","title":"每周股票复盘:华润江中(600750)证券简称2026年1月30日启用","url":"https://stock-news.laohu8.com/highlight/detail?id=2608077245","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608077245?lang=zh_cn&edition=full","pubTime":"2026-02-01 03:21","pubTimestamp":1769887272,"startTime":"0","endTime":"0","summary":"截至2026年1月30日收盘,华润江中报收于24.86元,较上周的23.44元上涨6.06%。本周,华润江中1月30日盘中最高价报25.2元,股价触及近一年最高点。证券简称变更实施日期为2026年1月30日,经公司申请并获上海证券交易所办理。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020100001118.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["161027","600750","BK0175","BK0028","BK0188","BK0239"],"gpt_icon":0},{"id":"2606219854","title":"江中药业最新公告:证券简称变更为华润江中","url":"https://stock-news.laohu8.com/highlight/detail?id=2606219854","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606219854?lang=zh_cn&edition=full","pubTime":"2026-01-26 18:18","pubTimestamp":1769422685,"startTime":"0","endTime":"0","summary":"江中药业(600750.SH)公告称,公司证券简称将于2026年1月30日起由“江中药业”变更为“华润江中”,股票证券代码“600750”保持不变。此次变更有助于强化与华润的品牌协同认知,进一步提升公司品牌辨识度和市场影响力。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012600024826.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0188","BK0239","161027","BK0175","600750"],"gpt_icon":0},{"id":"2606232809","title":"每周股票复盘:江中药业(600750)净利增14.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2606232809","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606232809?lang=zh_cn&edition=full","pubTime":"2026-01-25 02:22","pubTimestamp":1769278933,"startTime":"0","endTime":"0","summary":"截至2026年1月23日收盘,江中药业报收于23.44元,较上周的22.56元上涨3.9%。业绩披露要点江中药业近日即将发布2025年年报,根据1月23日发布的业绩快报,归属净利润盈利9.061亿元,同比增长14.96%。江中药业2025年年度业绩快报公告显示,营业总收入为421,950万元,同比下降4.87%;营业利润为119,851万元,同比增长16.55%;归属于上市公司股东的净利润为90,612万元,同比增长14.96%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012500000689.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0175","600750","BK0028","BK0188","BK0239"],"gpt_icon":0},{"id":"2605406825","title":"江中药业(600750)披露2025年年度业绩快报,1月23日股价上涨3.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2605406825","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605406825?lang=zh_cn&edition=full","pubTime":"2026-01-23 22:38","pubTimestamp":1769179099,"startTime":"0","endTime":"0","summary":"截至2026年1月23日收盘,江中药业报收于23.44元,较前一交易日上涨3.08%,最新总市值为148.83亿元。该股当日开盘22.73元,最高23.52元,最低22.73元,成交额达2.34亿元,换手率为1.61%。近日,华润江中药业股份有限公司发布2025年年度业绩快报,营业总收入为421,950万元,同比下降4.87%;营业利润为119,851万元,同比增长16.55%;归属于上市公司股东的净利润为90,612万元,同比增长14.96%。基本每股收益1.43元,加权平均净资产收益率22.74%,较上年同期上升3.16个百分点。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012300043283.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","600750","BK0028","BK0175","BK0188"],"gpt_icon":0},{"id":"2605479162","title":"华润医药(03320):江中药业2025年实现归母净利9.06亿元 同比增长14.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2605479162","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605479162?lang=zh_cn&edition=full","pubTime":"2026-01-23 18:34","pubTimestamp":1769164457,"startTime":"0","endTime":"0","summary":"智通财经APP讯,华润医药(03320)公布,2025年,江中药业实现营业收入人民币42.20亿元,同比下降4.87%,实现归属于上市公司股东的净利润人民币9.06亿元,同比增长14.96%。本报告期内,面对行业结构性调整压力,江中药业持续加强品牌打造,围绕“大单品、强品类”夯实核心业务根基。此外,江中药业丰富行销策略,强化投入回报,优化费用结构,并深化精益制造,推进降本增效,助力盈利水平提升。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1396767.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["03320","600750","BK1191","BK0188","BK0028","BK1570","BK0239","BK0175"],"gpt_icon":0},{"id":"2604154679","title":"阿里健康上线首个自研医学大模型;江中药业证券简称变为华润江中","url":"https://stock-news.laohu8.com/highlight/detail?id=2604154679","media":"21世纪经济报道","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604154679?lang=zh_cn&edition=full","pubTime":"2026-01-20 08:46","pubTimestamp":1768870017,"startTime":"0","endTime":"0","summary":"政策动向中医体质分类与判定国家标准首次制定发布1月19日,记者今天了解到,市场监管总局(国家标准委)批准发布《中医体质分类与判定》国家标准。该标准由国家中医药管理局组织起草,将自4月1日起正式实施。《中医体质分类与判定》规定了中医9种基本类型的特征、中医体质分类的判定,主要具有三方面特点。一是应用场景全域覆盖。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202601203623966731.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202601203623966731.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1502","BK1617","BK1615","BK1189","BK0188","BK0239","BK1591","BK1515","BK1584","BK1501","BK1571","600750","BK0175","161027","BK1589","BK1142","BK0028","BK1247","BK1610"],"gpt_icon":1},{"id":"2604310191","title":"江中药业(600750)披露拟变更证券简称公告,1月19日股价上涨0.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2604310191","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604310191?lang=zh_cn&edition=full","pubTime":"2026-01-19 22:51","pubTimestamp":1768834271,"startTime":"0","endTime":"0","summary":"截至2026年1月19日收盘,江中药业报收于22.66元,较前一交易日上涨0.44%,最新总市值为143.88亿元。公司近日发布公告称,华润江中药业股份有限公司于2025年12月12日召开董事会、2025年12月29日召开股东大会,审议通过变更公司名称、证券简称及注册资本等事项。公司中文名称由“江中药业股份有限公司”变更为“华润江中药业股份有限公司”,英文名称同步变更,并已完成工商变更登记。本次变更证券简称尚需经上海证券交易所批准,存在不确定性。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011900036111.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0175","BK0188","BK0028","600750","161027","BK0239"],"gpt_icon":0},{"id":"1152954584","title":"江中药业拟更名华润江中药业股份有限公司","url":"https://stock-news.laohu8.com/highlight/detail?id=1152954584","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1152954584?lang=zh_cn&edition=full","pubTime":"2026-01-19 16:56","pubTimestamp":1768812998,"startTime":"0","endTime":"0","summary":"江中药业宣布,公司计划将名称变更为华润江中药业股份有限公司。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0028","BK0239","600750","BK0175","BK0188"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1774566508150,"stockEarnings":[{"period":"1week","weight":0.0098},{"period":"1month","weight":0.0394},{"period":"3month","weight":0.0936},{"period":"6month","weight":0.2122},{"period":"1year","weight":0.1978},{"period":"ytd","weight":0.1148}],"compareEarnings":[{"period":"1week","weight":-0.0293},{"period":"1month","weight":-0.0555},{"period":"3month","weight":-0.0188},{"period":"6month","weight":0.0159},{"period":"1year","weight":0.1545},{"period":"ytd","weight":-0.0201}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"华润江中药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"30360人(较上一季度减少7.28%)","perCapita":"20707股","listingDate":"1996-09-23","address":"江西省南昌市青山湖区高新区火炬大道788号","registeredCapital":"63561万元","survey":" 华润江中药业股份有限公司的主营业务是药品和大健康产品的生产、研发与销售。公司的主要产品是健胃消食片、乳酸菌素片、双歧杆菌三联活菌肠溶胶囊、多维元素片、复方草珊瑚含片、复方鲜竹沥液、川贝枇杷胶囊、牛黄蛇胆川贝液、复方瓜子金颗粒、氨咖黄敏口服溶液等。公司累计授权专利300余项,参与2项国家标准、20余项中药饮片炮制规范的制定,荣获国家科学技术进步奖二等奖1项,省级科技进步奖4项,连续三年在国务院国资委“科改示范企业”专项考核中获评“优秀”。","listedPrice":6.8},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.38.0","shortVersion":"4.38.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"华润江中(600750)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供华润江中(600750)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"华润江中,600750,华润江中股票,华润江中股票老虎,华润江中股票老虎国际,华润江中行情,华润江中股票行情,华润江中股价,华润江中股市,华润江中股票价格,华润江中股票交易,华润江中股票购买,华润江中股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"华润江中(600750)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供华润江中(600750)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}